Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
26,32 USD | -10,70 % | +12,52 % | +890,27 % |
16.09. | Summit Therapeutics meldet hohe Ansprechraten von Ivonescimab-Studien in Krebsstudien | MT |
13.09. | Biontech springen hoch vor 'Esmo'-Kongress | DP |
Zu einer Liste hinzufügen 0 ausgewählt | KGV | Price to Book | PEG | EV / Sales | Marktkap. / EBITDA | Marktkap. / EBIT | Dividendenrendite (Y) | Kap. ($) | |
---|---|---|---|---|---|---|---|---|---|
-246.97x | 7,695 | 2.16x | 10.83x | 142.55x | 193.03x | -.--% | 126 Mrd. | ||
30.95x | 4,258 | 4.32x | 8.14x | 19.84x | 21.77x | -.--% | 124 Mrd. | ||
-527.02x | 7,369 | 6.53x | 14.5x | -176.06x | -166.91x | -.--% | 32,29 Mrd. | ||
-46.31x | 1,354 | 0.28x | 5.15x | -14.58x | -11.68x | -.--% | 29,36 Mrd. | ||
-32.26x | 6,266 | 1.15x | 5.3x | -32.57x | -26.98x | -.--% | 20,89 Mrd. | ||
21.53x | 3,399 | 0.86x | 4.24x | 13.89x | 14.58x | -.--% | 16,82 Mrd. | ||
12.13x | 1,883 | 8.99x | 2.65x | 7.52x | 9.04x | +2,42% | 16,04 Mrd. | ||
-25.49x | - | -3.09x | - | - | - | -.--% | 14,13 Mrd. | ||
-14.09x | -57,174300 | 5.26x | 36.79x | -17.16x | -16.6x | -.--% | 12,58 Mrd. | ||
28.58x | 4,368 | 0.39x | 4.47x | 16.53x | 16.8x | -.--% | 12,34 Mrd. | ||
66.97x | 9,459 | -0.51x | 6.39x | 77.94x | 153.56x | -.--% | 11,86 Mrd. | ||
-81.04x | 6,670 | 8.78x | 120.01x | -86.23x | -69.39x | -.--% | 9,68 Mrd. | ||
-43.53x | 9,873 | 0.73x | 15.33x | -30.19x | -26.54x | -.--% | 9,39 Mrd. | ||
-18.22x | 1 394,15 | 0.94x | 24.05x | -22.36x | -22.04x | -.--% | 8 Mrd. | ||
18.84x | 14,46 | 0.32x | 8.94x | 15.82x | 16.99x | - | 7,97 Mrd. | ||
-152.11x | 11,84 | 1.29x | 22.47x | -368.38x | -146.93x | -.--% | 7,95 Mrd. | ||
17.71x | 3,247 | 0.13x | 3.31x | 11.89x | 13.16x | -.--% | 7,84 Mrd. | ||
-66.53x | 8,095 | -6.14x | - | -46.52x | -46.21x | - | 7,43 Mrd. | ||
Durchschnitt | -58,72x | 84,54 | 1,80x | 18,29x | -28,71x | -5,55x | +0,15 % | 26,41 Mrd. | |
Gewichteter Durchschnitt nach Marktkapitalisierung | -100,95x | 28,31 | 2,74x | 12,33x | 22,97x | 44,74x | +0,08 % |
- Börse
- Aktien
- A2QDFS Aktie
- Sektor Summit Therapeutics Inc.
- Sektorale Bewertungen
MarketScreener is also available in this country: United States.
Switch edition